Funding Rounds
Immatics Biotechnologies Series D round
Immatics BiotechnologiesImmatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Summary
Stage: Series D
Raised Amount: $43.74M
Raised Date: 2013-10-15
